The DOI matches its Crossref record.
Measurements of Visual Evoked Potentials in Parkinson's Disease
Abstract
Visual evoked potentials elicited by reversing grating patterns were recorded in 35 patients with Parkinson's disease and in 26 controls. The average latency of evoked potentials in patients with Parkinson's disease exceeded by two standard deviations the average of the age-matched control group of other neurological patients. Over two-thirds of all patients with Parkinson's disease had abnormal latency. In these patients latency did not correlate with age. In 5 patients the latency became less prolonged on levodopa therapy, suggesting that catecholaminergic pathways have either indirect or direct effects on the generation of visual evoked potentials. Extrapyramidal connections of the visual cortex, as well as retinal dopaminergic neurons, require further study in Parkinson's disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Evoked Potentials in Clinical Medicine
Chiappa, K. H., & Ropper, A. H. (1982) · New England Journal of Medicine · doi:10.1056/nejm198205203062004 · Cited by 1,155
Visual dysfunction in Parkinson’s disease
Weil, R. S., Schrag, A. E., Warren, J. D., Crutch, S. J., Lees, A. J., & Morris, H. R. (2016) · Brain · doi:10.1093/brain/aww175 · Cited by 481
TEMPORAL DISCRIMINATION IS ABNORMAL IN PARKINSON'S DISEASE
ARTIEDA, J., PASTOR, M. A., LACRUZ, F., & OBESO, J. A. (1992) · Brain · doi:10.1093/brain/115.1.199 · Cited by 417
The retina in Parkinson's disease
Archibald, N. K., Clarke, M. P., Mosimann, U. P., & Burn, D. J. (2009) · Brain · doi:10.1093/brain/awp068 · Cited by 408
OCULAR MOTOR DEFICITS IN PARKINSON'S DISEASE: II. CONTROL OF THE SACCADIC AND SMOOTH PURSUIT SYSTEMS
WHITE, O. B., SAINT-CYR, J. A., TOMLINSON, R. D., & SHARPE, J. A. (1983) · Brain · doi:10.1093/brain/106.3.571 · Cited by 406
Prospective study of hallucinations and delusions in Parkinson's disease
Holroyd, S. (2001) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.70.6.734 · Cited by 345
Visual control of locomotion in Parkinson's disease
Azulay, J.-P., Mesure, S., Amblard, B., Blin, O., Sangla, I., & Pouget, J. (1999) · Brain · doi:10.1093/brain/122.1.111 · Cited by 340
Bodis-Wollner, I. (1990) · Trends in Neurosciences · doi:10.1016/0166-2236(90)90113-o · Cited by 296
Self-citationInner Retinal Layer Thinning in Parkinson Disease
Hajee, M. E. (2009) · Archives of Ophthalmology · doi:10.1001/archophthalmol.2009.106 · Cited by 268
Cognition in Parkinson disease: An event‐related potential perspective
Hansch, E. C., Syndulko, K., Cohen, S. N., Goldberg, Z. I., Potvin, A. R., & Tourtellotte, W. W. (1982) · Annals of Neurology · doi:10.1002/ana.410110608 · Cited by 255
Chapter 10 Functional roles of dopamine in the vertebrate retina
Witkovsky, P., & Dearry, A. (1991) · Progress in Retinal Research · doi:10.1016/0278-4327(91)90031-v · Cited by 252
Visual dysfunction, neurodegenerative diseases, and aging
Jackson, G. R., & Owsley, C. (2003) · Neurologic Clinics · doi:10.1016/s0733-8619(02)00107-x · Cited by 226
Taste responses in patients with Parkinson’s disease.
Sienkiewicz-Jarosz, H. (2005) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2003.033373 · Cited by 98
Onofrj, M., Thomas, A., & Bonanni, L. (2007) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.7.12.1731 · Cited by 41
The role of nitric oxide on visual-evoked potentials in MPTP-induced Parkinsonism in mice
Aras, S., Tanriover, G., Aslan, M., Yargicoglu, P., & Agar, A. (2014) · Neurochemistry International · doi:10.1016/j.neuint.2014.04.014 · Cited by 30
Metadata
- Authors
- Bodis --Wollner, I., & Yahr, M. D.
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 1978-12-01
- Volume
- 101
- Issue
- 4
- Pages
- 661-671
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- OpenAlex
- W2128803223
- Cited by
- 310
- References
- 0
- FWCI
- 5.74
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.